{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T07:11:54Z","timestamp":1696489914562},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00101-023-01338-5","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T07:01:41Z","timestamp":1695884501000},"page":"757-770","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Wirkmechanismen und klinische Anwendung von Diuretika in der Intensivmedizin","Mechanisms of action and clinical application of diuretics in intensive care medicine"],"prefix":"10.1007","volume":"72","author":[{"given":"M.-L.","family":"Lindner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Lohmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. H.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Zacharowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. F.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"1338_CR1","first-page":"1","volume":"7","author":"JM Sands","year":"2010","unstructured":"Sands\u00a0JM, Verlander\u00a0J (2010) Functional anatomy of the kidney. Compr Toxicol 7:1\u201322","journal-title":"Compr Toxicol"},{"key":"1338_CR2","doi-asserted-by":"publisher","first-page":"F1218","DOI":"10.1152\/ajprenal.00381.2018","volume":"316","author":"CA Romero","year":"2019","unstructured":"Romero\u00a0CA, Carretero\u00a0OA (2019) Tubule-vascular feedback in renal autoregulation. Am J Physiol Renal Physiol 316:F1218\u2013F1226","journal-title":"Am J Physiol Renal Physiol"},{"key":"1338_CR3","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2215\/CJN.09400913","volume":"9","author":"MR Pollak","year":"2014","unstructured":"Pollak\u00a0MR, Quaggin\u00a0SE, Hoenig\u00a0MP, Dworkin\u00a0LD (2014) The glomerulus: the sphere of influence. Clin J Am Soc Nephrol 9:1461\u20131469","journal-title":"Clin J Am Soc Nephrol"},{"key":"1338_CR4","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2215\/CJN.12001017","volume":"13","author":"K Wang","year":"2018","unstructured":"Wang\u00a0K, Kestenbaum\u00a0B (2018) Proximal tubular secretory clearance: a\u00a0neglected partner of kidney function. Clin J Am Soc Nephrol 13:1291\u20131296","journal-title":"Clin J Am Soc Nephrol"},{"key":"1338_CR5","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.2215\/CJN.10391012","volume":"9","author":"NP Curthoys","year":"2014","unstructured":"Curthoys\u00a0NP, Moe\u00a0OW (2014) Proximal tubule function and response to acidosis. Clin J Am Soc Nephrol 9:1627\u20131638","journal-title":"Clin J Am Soc Nephrol"},{"key":"1338_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1152\/ajplegacy.1968.215.1.108","volume":"215","author":"T Morgan","year":"1968","unstructured":"Morgan\u00a0T, Berliner\u00a0RW (1968) Permeability of the loop of Henle, vasa recta, and collecting duct to water, urea, and sodium. Am J Physiol 215:108\u2013115","journal-title":"Am J Physiol"},{"key":"1338_CR7","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/cphy.c110019","volume":"2","author":"TL Pannabecker","year":"2012","unstructured":"Pannabecker\u00a0TL (2012) Structure and function of the thin limbs of the loop of Henle. Compr Physiol 2:2063\u20132086","journal-title":"Compr Physiol"},{"key":"1338_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1152\/advan.00037.2001","volume":"26","author":"S Kurbel","year":"2002","unstructured":"Kurbel\u00a0S, Dodig\u00a0K, Radi\u0107\u00a0R (2002) The osmotic gradient in kidney medulla: a\u00a0retold story. Adv Physiol Educ 26:278\u2013281","journal-title":"Adv Physiol Educ"},{"key":"1338_CR9","doi-asserted-by":"publisher","first-page":"F1143","DOI":"10.1152\/ajprenal.00396.2011","volume":"301","author":"GR Ares","year":"2011","unstructured":"Ares\u00a0GR, Caceres\u00a0PS, Ortiz\u00a0PA (2011) Molecular regulation of NKCC2 in the thick ascending limb. Am J Physiol Renal Physiol 301:F1143\u2013F1159","journal-title":"Am J Physiol Renal Physiol"},{"key":"1338_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1258\/acb.2011.011281","volume":"49","author":"D Wile","year":"2012","unstructured":"Wile\u00a0D (2012) Diuretics: a\u00a0review. Ann Clin Biochem 49:419\u2013431","journal-title":"Ann Clin Biochem"},{"key":"1338_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.physiol.65.050102.085730","volume":"65","author":"PD Bell","year":"2003","unstructured":"Bell\u00a0PD, Lapointe\u00a0JY, Peti-Peterdi\u00a0J (2003) Macula densa cell signaling. Annu Rev Physiol 65:481\u2013500","journal-title":"Annu Rev Physiol"},{"key":"1338_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10741-011-9245-3","volume":"17","author":"GM Felker","year":"2012","unstructured":"Felker\u00a0GM (2012) Loop diuretics in heart failure. Heart Fail Rev 17:305\u2013311","journal-title":"Heart Fail Rev"},{"key":"1338_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.ajkd.2021.09.029","volume":"80","author":"JE Novak","year":"2022","unstructured":"Novak\u00a0JE, Ellison\u00a0DH (2022) Diuretics in states of volume overload: core curriculum 2022. Am J Kidney Dis 80:264\u2013276","journal-title":"Am J Kidney Dis"},{"key":"1338_CR14","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.2215\/CJN.09630818","volume":"14","author":"DH Ellison","year":"2019","unstructured":"Ellison\u00a0DH (2019) Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol 14:1248\u20131257","journal-title":"Clin J Am Soc Nephrol"},{"key":"1338_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0002-9629(15)40678-0","volume":"319","author":"DC Brater","year":"2000","unstructured":"Brater\u00a0DC (2000) Pharmacology of diuretics. Am J Med Sci 319:38\u201350","journal-title":"Am J Med Sci"},{"key":"1338_CR16","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens\u00a0W, Dauw\u00a0J, Martens\u00a0P et\u00a0al (2022) Acetazolamide in acute decompensated heart failure with volume overload. N\u00a0Engl J Med 387:1185\u20131195","journal-title":"N Engl J Med"},{"key":"1338_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.120.051824","volume":"143","author":"SD Anker","year":"2021","unstructured":"Anker\u00a0SD, Butler\u00a0J, Filippatos\u00a0G et al (2021) Effect of empagliflozin on cardiovascular and renal outcomes in patients with heart failure by baseline diabetes status: results from the EMPEROR-reduced trial. Circulation 143:337\u2013349","journal-title":"Circulation"},{"key":"1338_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","volume":"83","author":"V Vallon","year":"2021","unstructured":"Vallon\u00a0V, Verma\u00a0S (2021) Effects of SGLT2 inhibitors on kidney and cardiovascular function. Annu Rev Physiol 83:503\u2013528","journal-title":"Annu Rev Physiol"},{"key":"1338_CR19","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.120.045691","volume":"142","author":"M Griffin","year":"2020","unstructured":"Griffin\u00a0M, Rao\u00a0VS, Ivey-Miranda\u00a0J et al (2020) Empagliflozin in heart failure: diuretic and cardiorenal effects. Circulation 142:1028\u20131039","journal-title":"Circulation"},{"key":"1338_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.122.059725","volume":"146","author":"MN Kosiborod","year":"2022","unstructured":"Kosiborod\u00a0MN, Angermann\u00a0CE, Collins\u00a0SP et\u00a0al (2022) Effects of empagliflozin on symptoms, physical limitations, and quality of life in patients hospitalized for acute heart failure: results from the EMPULSE trial. Circulation 146:279\u2013288","journal-title":"Circulation"},{"key":"1338_CR21","first-page":"1879","volume":"50","author":"D Ellison","year":"2012","unstructured":"Ellison\u00a0D, Hoorn\u00a0E, Wilcox\u00a0C (2012) Diuretics. Hypertens Kidney 50:1879\u20131916","journal-title":"Hypertens Kidney"},{"key":"1338_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens\u00a0W, Damman\u00a0K, Harjola\u00a0VP et\u00a0al (2019) The use of diuretics in heart failure with congestion\u2014a\u00a0position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21:137\u2013155","journal-title":"Eur J Heart Fail"},{"key":"1338_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","volume":"136","author":"G Burckhardt","year":"2012","unstructured":"Burckhardt\u00a0G (2012) Drug transport by Organic Anion Transporters (OATs). Pharmacol Ther 136:106\u2013130","journal-title":"Pharmacol Ther"},{"key":"1338_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.semnephrol.2011.09.003","volume":"31","author":"DC Brater","year":"2011","unstructured":"Brater\u00a0DC (2011) Update in diuretic therapy: clinical pharmacology. Semin Nephrol 31:483\u2013494","journal-title":"Semin Nephrol"},{"key":"1338_CR25","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1681\/ASN.V133798","volume":"13","author":"CS Wilcox","year":"2002","unstructured":"Wilcox\u00a0CS (2002) New insights into diuretic use in patients with chronic renal disease. J\u00a0Am Soc Nephrol 13:798\u2013805","journal-title":"J Am Soc Nephrol"},{"key":"1338_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.7326\/0003-4819-102-3-314","volume":"102","author":"MR Vasko","year":"1985","unstructured":"Vasko\u00a0MR, Cartwright\u00a0DB, Knochel\u00a0JP, Nixon\u00a0JV, Brater\u00a0DC (1985) Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 102:314\u2013318","journal-title":"Ann Intern Med"},{"key":"1338_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14779072.2022.2022474","volume":"20","author":"AE Peters","year":"2022","unstructured":"Peters\u00a0AE, Mentz\u00a0RJ, DeWald\u00a0TA, Greene\u00a0SJ (2022) An evaluation of torsemide in patients with heart failure and renal disease. Expert Rev Cardiovasc Ther 20:5\u201311","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1338_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ahj.2014.12.009","volume":"169","author":"J Buggey","year":"2015","unstructured":"Buggey\u00a0J, Mentz\u00a0RJ, Pitt\u00a0B et\u00a0al (2015) A\u00a0reappraisal of loop diuretic choice in heart failure patients. Am Heart\u00a0J 169:323\u2013333","journal-title":"Am Heart J"},{"key":"1338_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1388-9842(03)00150-8","volume":"5","author":"K M\u00fcller","year":"2003","unstructured":"M\u00fcller\u00a0K, Gamba\u00a0G, Jaquet\u00a0F, Hess\u00a0B (2003) Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV\u2014efficacy and quality of life. Eur J Heart Fail 5:793\u2013801","journal-title":"Eur J Heart Fail"},{"key":"1338_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","volume":"111","author":"MD Murray","year":"2001","unstructured":"Murray\u00a0MD, Deer\u00a0MM, Ferguson\u00a0JA et al (2001) Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 111:513\u2013520","journal-title":"Am J Med"},{"key":"1338_CR31","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jep.13261","volume":"26","author":"NA Sherif","year":"2020","unstructured":"Sherif\u00a0NA, Morra\u00a0ME, Thanh\u00a0LV et al (2020) Torasemide versus furosemide in treatment of heart failure: a\u00a0systematic review and meta-analysis of randomized controlled trials. J\u00a0Eval Clin Pract 26:842\u2013851","journal-title":"J Eval Clin Pract"},{"key":"1338_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1001\/jama.2022.23924","volume":"329","author":"RJ Mentz","year":"2023","unstructured":"Mentz\u00a0RJ, Anstrom\u00a0KJ, Eisenstein\u00a0EL et al (2023) Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial. JAMA 329:214\u2013223","journal-title":"JAMA"},{"key":"1338_CR33","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"MA Konstam","year":"2007","unstructured":"Konstam\u00a0MA, Gheorghiade\u00a0M, Burnett\u00a0JC Jr. et\u00a0al (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297:1319\u20131331","journal-title":"JAMA"},{"key":"1338_CR34","first-page":"700","volume":"38","author":"YH Lin","year":"2022","unstructured":"Lin\u00a0YH, Tsai\u00a0CH, Chiang\u00a0CE et al (2022) The efficacy and safety of short-term tolvaptan usage in patients with acute decompensated heart failure. Acta Cardiol Sin 38:700\u2013713","journal-title":"Acta Cardiol Sin"},{"key":"1338_CR35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ejhf.567","volume":"18","author":"M Christ","year":"2016","unstructured":"Christ\u00a0M, St\u00f6rk\u00a0S, D\u00f6rr\u00a0M et\u00a0al (2016) Heart failure epidemiology 2000\u20132013: insights from the German federal health monitoring system. Eur J Heart Fail 18:1009\u20131018","journal-title":"Eur J Heart Fail"},{"key":"1338_CR36","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1253\/circj.CJ-10-0869","volume":"74","author":"K Kee","year":"2010","unstructured":"Kee\u00a0K, Naughton\u00a0MT (2010) Heart failure and the lung. Circ\u00a0J 74:2507\u20132516","journal-title":"Circ J"},{"key":"1338_CR37","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCHEARTFAILURE.111.961789","volume":"4","author":"C Fallick","year":"2011","unstructured":"Fallick\u00a0C, Sobotka\u00a0PA, Dunlap\u00a0ME (2011) Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a\u00a0cause of decompensation. Circ Heart Fail 4:669\u2013675","journal-title":"Circ Heart Fail"},{"key":"1338_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","volume":"12","author":"JM ter Maaten","year":"2015","unstructured":"ter Maaten\u00a0JM, Valente\u00a0MA, Damman\u00a0K, Hillege\u00a0HL, Navis\u00a0G, Voors\u00a0AA (2015) Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol 12:184\u2013192","journal-title":"Nat Rev Cardiol"},{"key":"1338_CR39","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M et\u00a0al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J 42:3599\u20133726","journal-title":"Eur Heart J"},{"key":"1338_CR40","unstructured":"(2020) Arzneimittelkommission der Deutschen Apotheker. Vergleichstabelle: Diuretika. https:\/\/www.abda.de\/fileadmin\/user_upload\/assets\/Arzneimittelkommission\/Aequivalenzdosistabellen\/Diuretika_AEquivalenzdosistabelle.pdf. Zugegriffen: 10. Febr. 2023"},{"key":"1338_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/0885066611403260","volume":"27","author":"PE Marik","year":"2012","unstructured":"Marik\u00a0PE, Flemmer\u00a0M (2012) Narrative review: the management of acute decompensated heart failure. J\u00a0Intensive Care Med 27:343\u2013353","journal-title":"J Intensive Care Med"},{"key":"1338_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ejhf.74","volume":"16","author":"RJ Mentz","year":"2014","unstructured":"Mentz\u00a0RJ, Kjeldsen\u00a0K, Rossi\u00a0GP et\u00a0al (2014) Decongestion in acute heart failure. Eur J Heart Fail 16:471\u2013482","journal-title":"Eur J Heart Fail"},{"key":"1338_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13613-017-0260-y","volume":"7","author":"R Bellomo","year":"2017","unstructured":"Bellomo\u00a0R, Ronco\u00a0C, Mehta\u00a0RL et\u00a0al (2017) Acute kidney injury in the ICU: from injury to recovery: reports from the 5th\u00a0Paris International Conference. Ann Intensive Care 7:49","journal-title":"Ann Intensive Care"},{"key":"1338_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1471-2369-14-133","volume":"14","author":"SS Han","year":"2013","unstructured":"Han\u00a0SS, Kim\u00a0S, Ahn\u00a0SY et\u00a0al (2013) Duration of acute kidney injury and mortality in critically ill patients: a\u00a0retrospective observational study. BMC Nephrol 14:133","journal-title":"BMC Nephrol"},{"key":"1338_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum\u00a0JA, Lameire\u00a0N (2013) Diagnosis, evaluation, and management of acute kidney injury: a\u00a0KDIGO summary (Part 1). Crit Care 17:204","journal-title":"Crit Care"},{"key":"1338_CR46","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s00063-018-0413-2","volume":"113","author":"M Joannidis","year":"2018","unstructured":"Joannidis\u00a0M, Klein\u00a0SJ, John\u00a0S et\u00a0al (2018) Prevention of acute kidney injury in critically ill patients : recommendations from the renal section of the DGIIN, \u00d6GIAIN and DIVI. Med Klin Intensivmed Notfmed 113:358\u2013369","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"1338_CR47","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000501315","volume":"44","author":"D Patschan","year":"2019","unstructured":"Patschan\u00a0D, Patschan\u00a0S, Buschmann\u00a0I, Ritter\u00a0O (2019) Loop diuretics in acute kidney injury prevention, therapy, and risk stratification. Kidney Blood Press Res 44:457\u2013464","journal-title":"Kidney Blood Press Res"},{"key":"1338_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12882-016-0323-6","volume":"17","author":"R Claure-Del Granado","year":"2016","unstructured":"Claure-Del Granado\u00a0R, Mehta\u00a0RL (2016) Fluid overload in the ICU: evaluation and management. BMC Nephrol 17:109","journal-title":"BMC Nephrol"},{"key":"1338_CR49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrneph.2013.80","volume":"9","author":"MA Perazella","year":"2013","unstructured":"Perazella\u00a0MA, Coca\u00a0SG (2013) Three feasible strategies to minimize kidney injury in \u2019incipient AKI. Nat Rev Nephrol 9:484\u2013490","journal-title":"Nat Rev Nephrol"},{"key":"1338_CR50","doi-asserted-by":"publisher","first-page":"F958","DOI":"10.1152\/ajprenal.00476.2015","volume":"310","author":"X Huang","year":"2016","unstructured":"Huang\u00a0X, Dorhout\u00a0ME, Vos\u00a0P, Hamza\u00a0S, Braam\u00a0B (2016) Everything we always wanted to know about furosemide but were afraid to ask. Am J Physiol Renal Physiol 310:F958\u2013971","journal-title":"Am J Physiol Renal Physiol"},{"key":"1338_CR51","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1186\/cc13015","volume":"17","author":"LS Chawla","year":"2013","unstructured":"Chawla\u00a0LS, Davison\u00a0DL, Brasha-Mitchell\u00a0E et al (2013) Development and standardization of a\u00a0furosemide stress test to predict the severity of acute kidney injury. Crit Care 17:R207","journal-title":"Crit Care"},{"key":"1338_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jcrc.2013.10.004","volume":"29","author":"GD Kitsios","year":"2014","unstructured":"Kitsios\u00a0GD, Mascari\u00a0P, Ettunsi\u00a0R, Gray\u00a0AW (2014) Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a\u00a0meta-analysis. J\u00a0Crit Care 29:253\u2013259","journal-title":"J Crit Care"}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-023-01338-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-023-01338-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-023-01338-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T08:01:47Z","timestamp":1696406507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-023-01338-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1007\/s00101-023-01338-5","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"12 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>M.-L.\u00a0Lindner<\/b>: A.\u00a0Finanzielle Interessen: M.-L.\u00a0Lindner gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: angestellte \u00c4rztin, Abteilung f\u00fcr An\u00e4sthesiologie, Intensiv- und Notfallmedizin | Mitgliedschaften: DGAI, AGNN. <b>J.L.\u00a0Lohmeyer<\/b>: A.\u00a0Finanzielle Interessen: L.\u00a0Lohmeyer gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Asklepios Klinik Altona, Abteilung f\u00fcr An\u00e4sthesiologie, Intensiv\u2011, Notfall- und Schmerzmedizin, Paul-Ehrlich-Stra\u00dfe\u00a01, 22763 Hamburg. <b>E.H.\u00a0Adam<\/b>: A.\u00a0Finanzielle Interessen: E.\u00a0Adam gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin, Universit\u00e4tsklinik Frankfurt am Main, Klinik f\u00fcr An\u00e4sthesiologie, Intensivmedizin und Schmerztherapie. <b>K.\u00a0Zacharowski<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Er ist Principal Investigator des EU-Horizon 2020-Projekts ENVISION (Intelligentes digitales Plug-and-Play-Tool f\u00fcr die Echtzeit-\u00dcberwachung von COVID-19-Patienten und intelligente Entscheidungsfindung auf Intensivstationen) und des Horizon Europe 2021-Projekts COVend (Biomarker und KI-gest\u00fctzte FXO6-Therapie zur Verhinderung des Fortschreitens von leichten und mittelschweren zu schweren Stadien von COVID 19). Die Klinik und Poliklinik f\u00fcr An\u00e4sthesiologie, Intensivmedizin und Schmerztherapie des Universit\u00e4tsklinikums Frankfurt an der Goethe-Universit\u00e4t erhielt Unterst\u00fctzung von B. Braun Melsungen, CSL Behring, Fresenius Kabi und Vifor Pharma f\u00fcr die Umsetzung des Frankfurter Patientenblut-Management-Programms.\u00a0\u2013 K. Zacharowski erhielt Honorare f\u00fcr die Teilnahme an Beiratssitzungen f\u00fcr Haemonetics und Vifor und erhielt Rednerhonorare von Masimo, Pharmacosmos, Boston Scientific, Salus, ISEP, Edwards und GE Healthcare. | K. Zacharowski leitet als Vorstandsvorsitzender die Christoph Lohfert Stiftung sowie die Stiftung Gesundheit, Patientensicherheit & BM.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Universit\u00e4tsklinikum Frankfurt, Klinik f\u00fcr An\u00e4sthesiologie, Intensivmedizin und Schmerztherapie, Theodor Stern Kai\u00a07, 60590 Frankfurt | Mitgliedschaften: DGAI, BDA, Deutsche Sepsis-Gesellschaft, Royal College of Anaesthetists, Deutsche Gesellschaft f\u00fcr Kardiologie\u00a0\u2013 Herz und Kreislaufforschung, ESAIC, ESICM, IMW Vet. Club, Rotary Club Frankfurt-Main-Skyline, Leopoldina, Frankfurter Gesellschaft f\u00fcr Handel Industrie und Wissenschaft e.\u202fV. <b>C.F.\u00a0Weber<\/b>: A.\u00a0Finanzielle Interessen: C.\u00a0Weber gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Asklepios Klinik Wandsbek, Abteilung f\u00fcr An\u00e4sthesiologie, Intensiv- und Notfallmedizin, Alphonsstra\u00dfe\u00a014, 22043 Hamburg.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}